Over the past few years, a new class of injectable medications has changed the way obesity is treated. Two drugs—tirzepatide ...

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

When treating obesity, semaglutide may be associated with a reduced fracture risk compared with sleeve gastrectomy.

Cleveland Clinic experts reveals what's behind "Ozempic face," and list the semaglutide-associated symptoms that can call for medical attention.

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

However, many on Wall Street believe that better days lie ahead for Novo Nordisk. Analysts expect this obesity drug stock to ...

The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...

In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or ...

For those preferring a drug-free approach to weight loss, research shows that certain nutrients and dietary strategies can ...

The benefit was seen as soon as 3 months. Investigators say there should be no delaying treatment for eligible patients.

In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...

Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...